BioSpace News Archive

Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD) (Nasdaq: TMDI), a medical device company focused on the design and development of robotic surgical technologies for single access surgery, today announced the election of Paul Cataford, Anthony J. Giovinazzo and Cary G. Vance to its Board of Directors.

ASYMTEK, a part of Nordson ELECTRONICS SOLUTIONS - a global leader in electronics manufacturing technologies, announces its latest technology has received the Global Technology Award 2020 for fluid dispensing equipment.

Akili today announced the expansion of the company’s executive team with the appointment of Meghan Rivera to the role of Chief Marketing Officer.

Urovant Sciences (Nasdaq: UROV) today announced it has entered into a five-year U.S. co-promotion agreement with Sunovion Pharmaceuticals Inc. to promote vibegron in the primary care segment upon receiving U.S. Food and Drug Administration (FDA) approval for the drug.

Horizon Therapeutics plc (Nasdaq: HZNP) today announced that it has been named one of “San Francisco Bay Area’s Best and Brightest Companies to Work For.”

Nascent Biotech, Inc. announces that the Company is in the process of making significant additions to its core team in order to prepare for the initiation of key Phase One clinical trials to study the safety and efficacy of the Company’s flagship drug, Pritumumab, a monoclonal antibody, for the treatment of Brain Cancer.

Biocare Medical, a leading provider of innovative, automated immunohistochemistry (IHC) reagents and instrumentation, announces the launch of three novel IVD IHC antibody markers at the forefront of clinical diagnostic and research applications.

Researchers at MINES ParisTech, one of France’s most prestigious engineering schools, have implemented Panasas® ActiveStor® high-performance computing (HPC) data storage to support the rapidly growing research efforts at the university’s Materials Research Center.

Polarean Imaging plc (AIM: POLX), the medical‑imaging technology company, with an investigational drug‑device combination product for magnetic resonance imaging (MRI), announces its submission of a New Drug Application (“NDA”) and request for priority review to the US Food and Drug Administration (“FDA”) for hyperpolarised 129Xenon gas used to evaluate pulmonary function and to visualise the lung using MRI.

OPTEC International, Inc (OTC PINK:OPTI) today announced the company surpassed the financial income projections for the Quarter ending September 30, 2020.